Sachetta »

Crispr Therapeutics shares owned by Sachetta

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Sachetta from 13F filings

Historical chart of Sachetta investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Sachetta consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Sachetta

Quarter filed Position value Share count Share price at filing
2024-03-31 $56k 896 62.60
2023-12-31 $56k 896 62.60

More positions owned by Sachetta

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Rus 1000 Etf (IWB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Ishares Tr North Amern Nat (IGE)
Ishares Tr U.s. Bas Mtl Etf (IYM)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Tr Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)
Wisdomtree Tr Itl Hdg Qtly Div (IHDG)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Mbs Etf (MBB)
Spdr Ser Tr S&p Divid Etf (SDY)
Ishares Tr Core S&p500 Etf (IVV)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)

View all positions for Sachetta

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Citadel Advisors
Vanguard Group
NEA Management Company
Susquehanna International
Caption Management
Dimensional Fund Advisors
Bellevue Group
Credit Suisse
T. Rowe Price Associates
Bank of America Corporation
Voloridge Investment Management
Ikarian Capital

View all funds holding Crispr Therapeutics